Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 14 Sep 2010, 9:00 AIP - Adcock Ingram Holdings Limited - Update on the call option process
AIP
AIP                                                                             
AIP - Adcock Ingram Holdings Limited - Update on the call option process        
initiated by Baxter Healthcare SA and further renewal of cautionary announcement
Adcock Ingram Holdings Limited                                                  
(Incorporated in the Republic of South Africa)                                  
Registration number 2007/016236/06                                              
Share code: AIP                                                                 
ISIN: ZAE000123436                                                              
("Adcock Ingram" or "the Company")                                              
Update on the call option process initiated by Baxter Healthcare SA ("Baxter")  
in respect of Adcock Ingram Critical Care (Pty) Limited ("AICC") and further    
renewal of cautionary announcement                                              
Reference is made to the various announcements released by the Company on SENS, 
the latest being 2 August 2010, relating to the call option process initiated by
Baxter in terms of the agreement between, inter alia, Baxter, Adcock Ingram and 
AICC dated 17 July 2008 ("the Option Agreement").                               
A dispute has arisen between Baxter and Adcock Ingram as to what the price is at
which Baxter may exercise the call option in the Option Agreement ("Call        
Option"), having regard to the written report dated 12 July 2010 prepared by    
KPMG Services (Proprietary) Limited.                                            
Shareholders are advised that the parties to the Option Agreement have agreed to
submit the dispute to arbitration.  The arbitration is due to be heard in       
February 2011.                                                                  
The Option Agreement has been amended such that, inter alia, Baxter will be     
entitled to exercise the Call Option within a period of three weeks following   
the earlier of the date on which (1) Adcock Ingram and Baxter agree in writing  
on the "Fair Market Value Determination" (as that term is defined in the Option 
Agreement) in respect of the shares in AICC which are the subject of the Call   
Option (2) and the arbitrators give their written award in the arbitration.     
Accordingly, shareholders are advised to continue exercising caution when       
dealing in Adcock Ingram securities until a further announcement is made.       
Midrand                                                                         
14 September 2010                                                               
Financial adviser and Sponsor                                                   
Deutsche Securities (SA) (Proprietary) Limited                                  
Date: 14/09/2010 09:00:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: